Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Short Interest Update

Bioceres Crop Solutions Corp. (NASDAQ:BIOX) saw a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 717,500 shares, an increase of 10.7% from the December 15th total of 648,400 shares. Currently, 2.2% of the company’s shares are short sold. Based on an average daily trading volume, of 193,500 shares, the days-to-cover ratio is currently 3.7 days.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of BIOX. Dimensional Fund Advisors LP grew its holdings in Bioceres Crop Solutions by 9.5% in the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock worth $688,000 after purchasing an additional 5,341 shares during the period. Stifel Financial Corp boosted its position in shares of Bioceres Crop Solutions by 33.4% in the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock worth $321,000 after purchasing an additional 10,224 shares in the last quarter. JPMorgan Chase & Co. grew its stake in shares of Bioceres Crop Solutions by 49.3% in the 3rd quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock worth $708,000 after buying an additional 29,693 shares during the last quarter. Long Focus Capital Management LLC increased its position in Bioceres Crop Solutions by 19.9% during the 2nd quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company’s stock valued at $3,145,000 after buying an additional 46,647 shares in the last quarter. Finally, Fourth Sail Capital LP raised its stake in Bioceres Crop Solutions by 61.6% during the third quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company’s stock valued at $24,957,000 after buying an additional 1,209,277 shares during the last quarter. 17.68% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

A number of brokerages have issued reports on BIOX. Oppenheimer cut their price target on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a report on Monday, October 21st. Canaccord Genuity Group cut their target price on Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating on the stock in a research note on Wednesday, November 13th. Four research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $12.13.

Bioceres Crop Solutions Stock Down 0.3 %

BIOX traded down $0.02 on Friday, hitting $6.89. The company had a trading volume of 123,341 shares, compared to its average volume of 134,753. The stock has a fifty day simple moving average of $6.58 and a 200-day simple moving average of $8.28. The company has a debt-to-equity ratio of 0.37, a current ratio of 1.27 and a quick ratio of 0.87. The firm has a market capitalization of $433.04 million, a P/E ratio of 344.67 and a beta of 0.56. Bioceres Crop Solutions has a 52-week low of $5.71 and a 52-week high of $14.05.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings results on Monday, November 11th. The company reported ($0.09) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.11). The firm had revenue of $92.60 million for the quarter, compared to the consensus estimate of $117.15 million. Bioceres Crop Solutions had a net margin of 0.53% and a return on equity of 0.68%. During the same quarter in the prior year, the firm earned ($0.07) earnings per share. As a group, equities analysts expect that Bioceres Crop Solutions will post 0.12 EPS for the current fiscal year.

Bioceres Crop Solutions Company Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.